Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

PURPOSE: To evaluate a panel of pretreatment clinical and laboratory parameters in metastatic melanoma (MM) in order to verify their impact on response and survival in a single prospective multi-institutional phase III study comparing out-patient chemotherapy (CT) vs bioCT. METHODS: A total of 176 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC320500/
https://www.ncbi.nlm.nih.gov/pubmed/14690541
http://dx.doi.org/10.1186/1479-5876-1-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC320500/
https://www.ncbi.nlm.nih.gov/pubmed/14690541
http://dx.doi.org/10.1186/1479-5876-1-13

Ejemplares similares